Filip Van Immerseel Selected Research

Enteritis

1/2021	Protein Truncating Variants of colA in Clostridium perfringens Type G Strains.
8/2020	C. perfringens challenge reduces matrix metalloproteinase activity in the jejunal mucosa of Eimeria-infected broiler chickens.
7/2018	Valeric acid glyceride esters in feed promote broiler performance and reduce the incidence of necrotic enteritis.
1/2018	Elevated faecal ovotransferrin concentrations are indicative for intestinal barrier failure in broiler chickens.
1/2017	Rethinking the role of alpha toxin in Clostridium perfringens-associated enteric diseases: a review on bovine necro-haemorrhagic enteritis.
6/2016	Toxin-neutralizing antibodies protect against Clostridium perfringens-induced necrosis in an intestinal loop model for bovine necrohemorrhagic enteritis.
6/2016	Variable protection against experimental broiler necrotic enteritis after immunization with the C-terminal fragment of Clostridium perfringens alpha-toxin and a non-toxic NetB variant.
1/2016	The Probiotic Butyricicoccus pullicaecorum Reduces Feed Conversion and Protects from Potentially Harmful Intestinal Microorganisms and Necrotic Enteritis in Broilers.
1/2016	The C-terminal domain of Clostridium perfringens alpha toxin as a vaccine candidate against bovine necrohemorrhagic enteritis.
1/2016	In Vitro Selective Growth-Inhibitory Effect of 8-Hydroxyquinoline on Clostridium perfringens versus Bifidobacteria in a Medium Containing Chicken Ileal Digesta.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Filip Van Immerseel Research Topics

Disease

19	Enteritis 01/2021 - 12/2004
10	Infections 08/2020 - 11/2006
6	Inflammation (Inflammations) 01/2021 - 01/2015
4	Communicable Diseases (Infectious Diseases) 01/2018 - 01/2014
4	Necrosis 02/2017 - 12/2013
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2015 - 02/2010
3	Dysbiosis 06/2015 - 08/2014
2	Colitis 01/2021 - 12/2013
2	Foodborne Diseases 10/2018 - 12/2004
2	Ulcerative Colitis 02/2017 - 08/2014
2	Salmonella Infections (Salmonellosis) 03/2008 - 05/2007
1	Hepatocellular Carcinoma (Hepatoma) 03/2022
1	Neoplasms (Cancer) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Hemolysis 08/2021
1	Weight Gain 07/2021
1	Shock 10/2020
1	Crohn Disease (Crohn's Disease) 10/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Diarrhea 10/2018
1	Coccidiosis 01/2018
1	Pouchitis 01/2017
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 06/2015
1	Bacterial Infections (Bacterial Infection) 01/2015
1	Carcinoma (Carcinomatosis) 01/2015
1	Enterotoxemia 01/2014
1	Body Weight (Weight, Body) 03/2008

Drug/Important Bio-Agent (IBA)

9	Anti-Bacterial Agents (Antibiotics)IBA 10/2018 - 12/2004
8	Butyrates (Butyrate)IBA 02/2017 - 08/2008
7	VaccinesIBA 05/2018 - 10/2007
5	Proteins (Proteins, Gene)FDA Link 08/2021 - 05/2007
4	Virulence Factors (Pathogenicity Factors)IBA 01/2017 - 03/2010
3	MycotoxinsIBA 06/2016 - 01/2014
2	EnzymesIBA 01/2021 - 01/2017
2	Collagenases (Collagenase)FDA Link 01/2021 - 01/2014
2	CytokinesIBA 10/2020 - 12/2013
2	Peptide Hydrolases (Proteases)FDA Link 08/2020 - 01/2014
2	Polysaccharides (Glycans)IBA 06/2016 - 12/2004
2	Clostridium perfringens alpha toxinIBA 06/2016 - 01/2016
2	Starch (Cornstarch)IBA 06/2016 - 12/2004
2	deoxynivalenolIBA 01/2014 - 01/2014
1	Neuraminidase (Sialidase)IBA 03/2022
1	Amino Acids FDA Link 01/2022
1	Alanine (L-Alanine)FDA Link 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	AgarIBA 08/2021
1	Vitamin E FDA LinkGeneric 07/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	DipeptidesIBA 01/2021
1	Dextran SulfateIBA 01/2021
1	Collagen Type IV (Type IV Collagen)IBA 01/2021
1	Peptidoglycan (Murein)IBA 01/2021
1	Muramidase (Lysozyme)IBA 01/2021
1	InterferonsIBA 10/2020
1	ZincIBA 10/2020
1	Matrix Metalloproteinases (MMPs)IBA 08/2020
1	Abscisic AcidIBA 01/2020
1	Plant Growth Regulators (Plant Hormones)IBA 01/2020
1	Indoleacetic Acids (Auxin)IBA 01/2020
1	CytokininsIBA 01/2020
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 01/2020
1	Biomarkers (Surrogate Marker)IBA 06/2019
1	Glycerides (Acylglycerol)IBA 07/2018
1	EstersIBA 07/2018
1	Glucagon (Glukagon)FDA Link 07/2018
1	n-pentanoic acid (valeric acid)IBA 07/2018
1	ConalbuminIBA 01/2018
1	Conditioned Culture MediaIBA 02/2017
1	Claudin-1IBA 02/2017
1	Neutralizing AntibodiesIBA 06/2016
1	Immunoglobulin A (IgA)IBA 06/2016
1	FumonisinsIBA 09/2015
1	Triclosan (pHisoHex)FDA Link 01/2015
1	SulfonamidesIBA 01/2015
1	Anti-Infective Agents (Microbicides)IBA 01/2015
1	Antimicrobial PeptidesIBA 01/2015
1	MucinsIBA 01/2015
1	Bacteriocins (Lantibiotics)IBA 04/2014
1	hyaluronate lyase (spreading factor)IBA 01/2014
1	Clostridium perfringens theta-toxinIBA 01/2014
1	InterleukinsIBA 12/2013
1	Peroxidase (Myeloperoxidase)IBA 12/2013
1	ToxoidsIBA 08/2013
1	Formaldehyde (Formol)FDA Link 08/2013
1	Biological ProductsIBA 12/2010
1	Butyric Acid (Butanoic Acid)IBA 02/2010
1	Lactic Acid (Lactate)FDA LinkGeneric 08/2008
1	PropionatesIBA 08/2008
1	Acetates (Acetic Acid Esters)FDA Link 08/2008
1	Volatile Fatty AcidsIBA 08/2008
1	florfenicolIBA 03/2008
1	Drinking WaterIBA 03/2008
1	Bile Acids and Salts (Bile Acids)IBA 10/2007
1	FlagellinIBA 05/2007
1	lambda Spi-1IBA 11/2006

Therapy/Procedure

3	Oral Administration 01/2021 - 12/2013
1	Therapeutics 01/2022
1	Restorative Proctocolectomy 01/2017
1	Colectomy 01/2017